期刊文献+

合并桥本氏甲状腺炎的甲状腺乳头状癌淋巴结转移的危险因素分析 被引量:2

Risk factors for lymph node metastasis in papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis
暂未订购
导出
摘要 目的分析合并桥本氏甲状腺炎的甲状腺乳头状癌颈部淋巴结转移的危险因素。方法采用回顾性分析方法,收集甲状腺乳头状癌合并桥本氏甲状腺炎患者的临床病理资料,如年龄、性别、肿瘤最大径、多灶性、淋巴结转移情况等,经单因素及多因素分析确定淋巴结转移的危险因素。结果收集病例112例,男21例,女91例;其中45例发生颈部淋巴结转移(40.17%);肿瘤最大径≤1cm者69例;多灶者42例;有砂粒体77例。单因素分析显示,年龄≥55岁、较小的肿瘤直径、多灶性和存在砂粒体是淋巴结转移的危险因素。多因素分析显示,年龄≥55岁、较小肿瘤直径以及肿瘤多灶性是颈部淋巴结转移的独立危险因素。结论年龄≥55岁、较小肿瘤直径以及多灶性是甲状腺乳头状癌合并桥本氏甲状腺炎淋巴结转移的危险因素,提示其淋巴结转移可能。 Objective To evaluate the risk factors of lymph node metastasis(LNM) in patients with papillary thyroid cancer(PTC) coexisting with Hashimoto's thyroiditis(HT). Methods Retrospectively studied the information of the patients with PTC and HT,including age gender,tumor size,mulifocality,lymph node metastasis. Multivariate analysis was performed to identify risk factors of LNM. Results Among 112 patients,21 cases were male, 91 cases were female. 45 cases had cervical lymph node metastasis(40.17%);69 cases of maximum diameter of tumors were smaller than 1 cm;42 cases were multifocal;77 cases had psammoma bodies. Univariate analysis showed that age more than or equal to 55 years,smaller tumor diameter,multifocal and psammoma bodies were risk factors for lymph node metastasis. Multivariate analysis showed that age more than or equal to 55 years,smaller tumor diameter and multifocality were independent risk factors for lymph node metastasis. Conclusion Age more than or equal to 55 years,smaller tumor diameter and multifocality are independent risk factors for LNM of patients who have PTC coexistent with HT,which suggest the possibility of lymph node metastasis.
出处 《中国现代医药杂志》 2018年第1期22-25,共4页 Modern Medicine Journal of China
关键词 乳头状癌 桥本 淋巴结转移 年龄 砂粒体 papillary thyroid cancer(PTC) coexisting Hashimoto's thyroiditis(HT) Retrospectively cervical lymph node metastasis
  • 相关文献

参考文献4

二级参考文献42

  • 1闫慧娴,谷伟军,杨国庆,黄薇,巴建明,王先令,杜锦,金楠,臧丽.桥本甲状腺炎与甲状腺乳头状癌关系的临床研究[J].中华内分泌代谢杂志,2014,30(4). 被引量:51
  • 2魏松锋,高明.桥本甲状腺炎并发甲状腺乳头状癌40例临床分析[J].中国实用外科杂志,2006,26(11):862-863. 被引量:26
  • 3Mazzaferri EL,Kloos RT.Clinical review 128:Current approaches to primary therapy for papillary and follicular thyroid cancer[J].J Clin Metab,2001,86(4):1447-1463
  • 4Hay ID.Papillary thyroid Carcinoma[J].Endocrinol Metab Clin North Am,1990,19:545
  • 5Hay ID,Bergstralh EJ,Grant CS,et al.Impact of PriMARY surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage Ⅲ papillary thyroid carcinoma treated at one institution from 1940-1989[J].Surgery,1999,126(6):1174-1182
  • 6Rouxel A,Hejblum G,Bernier MO,et al.Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas[J].J Clin Endocrin Metab,2004,89(11):5362-5368
  • 7Grant CS,Hay ID,Gough RI,et al.Local recurrence in papillary thyroid carcinoma:is extent of surgical resection important[J] ? Surgery,1988,104 (6):954-962
  • 8Bachelot A,Leboulleux S,Baudin E,et al.Neck Recurrence from thyroid carcinoma:Serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment[J].Clin Endocrinoal (Oxf),2005,62(3):376-379
  • 9Chow SM,Law SC,Au SK,et al.Changes in clinical presentation,management and outcome in 1348 patients with differentiated thyroid carcinoma:experience in a single institutue in Hong Kong,1960-2000[J].Clinical Oncology,2003,15:329-336
  • 10Patel KN,Shaha AR.Locally advanced thyroid cancer[J].Curr Opin Otolaryngol Head Neck Surg,2005,13(2):112-116

共引文献30

同被引文献7

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部